CAT# | AAD-088 |
CAS | 84000-09-9 |
Synonyms/Alias | N-Fmoc-N-ethyl-L-alanine; (S)-N-Fmoc-N-ethylalanine; SCHEMBL8804802; DTXSID80595368 |
Chemical Name | (2S)-2-[ethyl(9H-fluoren-9-ylmethoxycarbonyl)amino]propanoic acid |
M.F/Formula | C20H21NO4 |
M.W/Mr. | 339.4 |
InChI | InChI=1S/C20H21NO4/c1-3-21(13(2)19(22)23)20(24)25-12-18-16-10-6-4-8-14(16)15-9-5-7-11-17(15)18/h4-11,13,18H,3,12H2,1-2H3,(H,22,23)/t13-/m0/s1 | InChI Key | FIVAYWIQBITLAU-ZDUSSCGKSA-N | Canonical SMILES | CCN(C(C)C(=O)O)C(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13 | Isomeric SMILES | CCN([C@@H](C)C(=O)O)C(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13 |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
CP01332 | D-Leucine tert.butyl ester hydrochloride | Inquiry | ||
CP11308 | Cbz-4-tert-butyl-L-Phenylalanine | Inquiry | ||
CP26343 | (2R,3S)-3-Phenylisoserine | Inquiry | ||
AAD-072 | (2R,3S)-2-[Tert-butoxycarbonyl-(methyl)-amino]-3-hydroxy-butanoic acid | Inquiry | ||
CP02906 | Z-L-2-aminobutyric acid | Inquiry |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
10-101-20 | Goserelin Acetate | 1269.43 | C59H84N18O14 | Inquiry |
10-101-59 | Liraglutide | 3751.2 | C172H265N43O51 | Inquiry |
R1574 | Octreotide | 1019.24 | C₄₉H₆₆N₁₀O₁₀S₂ | Inquiry |
10-101-139 | Myrcludex B | Inquiry | ||
10-101-285 | Teduglutide | 3752.08 | C164H252N44O55S | Inquiry |
R1847 | Sermaglutide | 4114 | C187H291N45O59 | Inquiry |
R1961 | Carbetocin | 988.2 | C45H69N11O12S | Inquiry |
Required fields are marked with *
×Required fields are marked with *
×* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
The peptide neuroprotectant Tat-NR2B9c, also known as NA-1, is a Tat peptide consisting of the nine C-terminal ...
BA 1 (DTyr-Gln-Trp-Ala-Val- Ala-His-Phe-Nle-NH2) is a potent BRS-3 agonist (IC50 = 2.52 nM) and a NMBR and GRPR ...
Brief information of orexin peptide The past several years have provided important insights into the physiological significan ...
Insulin was discovered by Banting and Best in 1921. Soon afterwards manufacturing processes were developed to extract the ins ...
Since the discovery of Substance P (SP) in the early 1930s, its pharmacological actions have been extensively studied. SP has ...